Skip to content

A Clinical Study to Evaluate the Efficacy of Duralabhadi Avleha in the Management of Vataja Kasa(Allergic Bronchitis) in Children

A Randomized Controlled Clinical Study to Evaluate the Efficacy of Duralabhadi Avaleha in the Management of Vataja Kasa(Allergic Bronchitis) in Children - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/08/057155
Enrollment
80
Registered
2023-08-31
Start date
Unknown
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J40- Bronchitis, not specified as acuteor chronic

Interventions

None listed

Sponsors

Parul Institute of Ayurved
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Age group between 5yrs to 12yrs. 2) Patients of either gender will be included. 3) Patients with symptoms of vataja kasa like- shushka kasa , Urashool , shirashoola, parshvashool, swarbheda, shushka mukha and gala. 4) Patient with symptoms of Allergic Bronchitis:- Dry Cough , Chest tightness, Headache, Sore throat.

Exclusion criteria

Exclusion criteria: 1) Age group below 5yrs and more than 12yrs. 2) K/C/O fever, pneumonia, juvenile DM, Tuberculosis, Asthma should be excluded.

Design outcomes

Primary

MeasureTime frame
Improvement in episodes of coughTimepoint: At base line 3 days 7 days 12 days

Secondary

MeasureTime frame
Improvement in allergic symptoms like itchingTimepoint: At base line 3 days 7 days 12 days

Countries

India

Contacts

Public ContactDr. Bharti Changle

Parul Institute of Ayurved

brpatil04@gmail.com9687663916

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026